Comparison of Feeding Strategies for Hypoplastic Left Heart Syndrome

Status Completed

Clinical Trial Summary

The purpose of the study is to determine if a continuous feeding regimen as compared to an intermittent bolus feeding regimen leads to improved weight gain in infants with hypoplastic left heart syndrome (HLHS) after stage 1 procedures.

Clinical Trial Description

In recent years, survival after neonatal cardiac surgery has improved significantly. As life span has improved in HLHS/single ventricle variants (SVV) survivors, focus has shifted to the understanding and management of associated health problems. Growth failure is a well-recognized major co-morbidity in these patients.

Infants with HLHS/SVV demonstrate progressive growth failure after stage 1 procedures, which appears to stabilize only after stage 2 procedures. Poor nutritional status increases risk for post-operative infections, extends hospital length-of-stay, and adversely affects neurodevelopmental outcomes.

To date, evidence-based feeding strategies that support adequate weight gain and improve nutritional status have not been identified after stage 1 procedures. Continuous enteral feeding regimens have resulted in improved growth in a diverse population of infants with congenital heart disease and have been shown to decrease energy expenditure in premature infants and adults. A randomized, controlled study of HLHS/SVV infants who underwent stage 1 procedures at a single medical center was conducted with the primary objective of comparing weight gain at hospital discharge between infants receiving a continuous feeding regimen versus an intermittent feeding regimen. Secondary objectives were to compare growth and markers of nutritional status at hospital discharge between the two groups. The investigators hypothesized that infants with HLHS/SVV who receive a continuous enteral feeding regimen versus an intermittent feeding regimen will demonstrate improved weight gain, growth, and nutritional status after stage 1 procedures at hospital discharge. ;

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02657629
Study type	Interventional
Source	Columbia University
Contact
Status	Completed
Phase	N/A
Start date	December 2009
Completion date	November 2012

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01215240` - Prophylactic Peritoneal Dialysis Decreases Time to Achieve a Negative Fluid Balance After the Norwood Procedure	N/A
Completed	`NCT00513240` - Erythropoetin Neuroprotection for Neonatal Cardiac Surgery	Phase 1/Phase 2
Withdrawn	`NCT00156455` - Sleep Disordered Breathing in Children With Single Ventricle Physiology	N/A
Terminated	`NCT01445041` - Safety and Feasibility Study of Umbilical Cord Blood Cells for Infants With Hypoplastic Left Heart Syndrome	Phase 1
Recruiting	`NCT04581668` - Impact of NAVA Ventilation on Brain Oxygenation and Perfusion in Children With Congenital Heart Disease	N/A
Completed	`NCT01708863` - A Prospective Study of Patients With Hypoplastic Left Heart Syndrome (HLHS) Following Stage II Surgical Palliation
Completed	`NCT01736956` - Fetal Intervention for Aortic Stenosis and Evolving Hypoplastic Left Heart Syndrome	N/A
Recruiting	`NCT03406884` - The CHILD Trial: Hypoplastic Left Heart Syndrome Study.	Phase 1
Active, not recruiting	`NCT03079401` - Mesoblast Stem Cell Therapy for Patients With Single Ventricle and Borderline Left Ventricle	Phase 1/Phase 2
Completed	`NCT02306057` - Fluid Balance in Children Undergoing Fontan Surgery	N/A
Terminated	`NCT01107990` - Global and Regional Myocardial Strain and Power Output In Patients With Single Ventricles Using Novel MRI Techniques
Completed	`NCT01883076` - Safety Study of Autologous Umbilical Cord Blood Cells for Treatment of Hypoplastic Left Heart Syndrome	Phase 1
Completed	`NCT04056416` - Physical Activity Promotion in Children and Adolescents With Single Ventricle Physiology (MedBike)	N/A
Completed	`NCT01656941` - Genetic Determinants of Congenital Heart Disease Outcomes
Completed	`NCT00464100` - Near-infrared Spectroscopy (NIRS) Neurodevelopmental Outcomes
Active, not recruiting	`NCT03779711` - Intramyocardial Injection of Autologous Umbilical Cord Blood Derived Mononuclear Cells During Surgical Repair of Hypoplastic Left Heart Syndrome	Phase 2
Recruiting	`NCT04925024` - Evaluation of Lomecel-B™ Injection in Patients With Hypoplastic Left Heart Syndrome (HLHS): A Phase IIb Clinical Trial.	Phase 2
Recruiting	`NCT02781922` - Cardiac Stem/Progenitor Cell Infusion in Univentricular Physiology (APOLLON Trial)	Phase 3
Completed	`NCT01582529` - SVRII Family Factors Study
Completed	`NCT00974025` - Impact of Vitamin C on Endothelial Function and Exercise Capacity in Fontan-Palliated Patients	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Comparison of Feeding Strategies for Hypoplastic Left Heart Syndrome Infants

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms